Mark Bertolini Sells 591,168 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini sold 591,168 shares of the firm’s stock in a transaction on Friday, June 26th. The shares were sold at an average price of $29.28, for a total value of $17,309,399.04. Following the completion of the sale, the chief executive officer owned 8,990,566 shares in the company, valued at approximately $263,243,772.48. This represents a 6.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Trading Down 3.1%

NYSE:OSCR opened at $28.54 on Wednesday. Oscar Health, Inc. has a 1 year low of $10.69 and a 1 year high of $30.66. The stock has a market cap of $8.61 billion, a P/E ratio of -48.38, a P/E/G ratio of 2.06 and a beta of 2.37. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.11 and a current ratio of 1.11. The stock has a 50-day simple moving average of $23.56 and a 200-day simple moving average of $17.55.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, beating the consensus estimate of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The company had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.90 billion. During the same period in the prior year, the firm posted $0.92 earnings per share. The firm’s revenue was up 52.6% on a year-over-year basis. As a group, analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Institutional Trading of Oscar Health

Large investors have recently bought and sold shares of the business. Quarry LP grew its position in Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after purchasing an additional 1,469 shares during the last quarter. Jones Financial Companies Lllp raised its holdings in shares of Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares during the last quarter. Strs Ohio acquired a new stake in shares of Oscar Health during the first quarter worth about $30,000. Fifth Third Bancorp boosted its stake in shares of Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after buying an additional 1,413 shares during the period. Finally, Binnacle Investments Inc purchased a new position in shares of Oscar Health during the second quarter worth about $75,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

OSCR has been the subject of a number of research reports. UBS Group boosted their price target on shares of Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Barclays raised Oscar Health from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $30.00 to $35.00 in a report on Wednesday, June 10th. Weiss Ratings cut Oscar Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, June 24th. Wall Street Zen raised Oscar Health from a “buy” rating to a “strong-buy” rating in a report on Sunday, June 14th. Finally, Zacks Research cut Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 5th. Three analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $20.78.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.